GF
BHVN icon

Gabelli Funds’s Biohaven BHVN Stock Holding History

Gabelli Funds’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,500
Closed -$204K – 1227
2025
Q1 		$204K Sell
8,500
-500
-6% -$17.6K ﹤0.01% 1006
2024
Q4 		$336K Sell
9,000
-4,200
-32% -$196K ﹤0.01% 954
2024
Q3 		$660K Sell
13,200
-7,300
-36% -$284K ﹤0.01% 857
2024
Q2 		$712K Sell
20,500
-5,500
-21% -$217K 0.01% 840
2024
Q1 		$1.42M Hold
26,000
– – 0.01% 723
2023
Q4 		$1.11M Hold
26,000
– – 0.01% 766
2023
Q3 		$676K Hold
26,000
– – 0.01% 865
2023
Q2 		$622K Hold
26,000
– – ﹤0.01% 880
2023
Q1 		$355K Hold
26,000
– – ﹤0.01% 967
2022
Q4 		$361K Buy
+26,000
New +$367K ﹤0.01% 993

Other funds holding BHVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Gabelli Funds's BHVN Position: Q2 2025 in Review

Gabelli Funds sold out of Biohaven (BHVN) in Q2 2025, closing a stake of 8,500 shares — an estimated $204K sold.

Gabelli Funds first reported a position in BHVN in Q4 2022 and held it in 10 quarters. The position peaked at $1.42M in Q1 2024. 249 funds tracked by Wall St. Rank hold BHVN as of Q2 2025.

  • Gabelli Funds reported no remaining Biohaven position as of Q2 2025 after selling out during the quarter.
  • Gabelli Funds sold 8,500 Biohaven shares in Q2 2025, an estimated $204K.
  • Gabelli Funds first reported a position in Biohaven in Q4 2022 and held it in 10 quarters.
  • Gabelli Funds's Biohaven position peaked at $1.42M in Q1 2024.
  • 249 funds tracked by Wall St. Rank held Biohaven as of Q2 2025.

Based on Gabelli Funds's 13F filing for Q2 2025, filed 13 Aug 2025.